v3.0.7
Please consider this website is continuously evolving and still under development
to harmonize automatic data extraction and integrate manual data annotation.
| Column | Value |
|---|---|
| Trial registration number | NCT04896866 |
|
Full text link
Last imported at : May 25, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
|
|
First author
Last imported at : May 13, 2022, 7 a.m. Source : ClinicalTrials.gov |
|
|
Contact
Last imported at : May 13, 2022, 7 a.m. Source : ClinicalTrials.gov |
Not reported |
|
Registration date
Last imported at : May 25, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
2021-05-21 |
|
Recruitment status
Last imported at : April 5, 2023, 8 p.m. Source : ClinicalTrials.gov |
Completed |
|
Study design
Last imported at : May 25, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
RCT |
|
Allocation
Last imported at : May 25, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
Randomized |
|
Design
Last imported at : May 25, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
Parallel |
|
Masking
Last imported at : May 25, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
Open label |
|
Center
Last imported at : March 15, 2023, 4 a.m. Source : ClinicalTrials.gov |
multi-center |
|
Study aim
Last imported at : May 25, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
Treatment |
|
Inclusion criteria
Last imported at : May 25, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
inclusion criteria: - age ≥18 years at the time of hospital admission. - confirmed sars-cov-2 infection by nucleic acid testing in the preceding 14 days of hospital admission. - admitted from the community (including continuing care facilities). - admitted to a hospital bed designated in the study. - spo2 ≤94% requiring supplemental oxygen or chest imaging findings compatible with covid-19 pneumonia. |
|
Exclusion criteria
Last imported at : Oct. 22, 2021, 10 a.m. Source : ClinicalTrials.gov |
- the patient is enrolled in another clinical trial that involves antibacterial therapy. - the patient's goals of care is anticipated to be designated "total compassionate care" or palliative care within 48 hours of admission. - the patient's progression to death is anticipated to be imminent and inevitable within 48 hours of admission. - the patient was attended by any member of the research team within 30 days of enrollment. - the patient is transferred from another acute care center. |
|
Number of arms
Last imported at : May 25, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
2 |
|
Funding
Last imported at : May 25, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
University of Alberta |
|
Inclusion age min
Last imported at : May 25, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
18 |
|
Inclusion age max
Last imported at : May 25, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
100 |
|
Countries
Last imported at : May 25, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
Canada |
|
Type of patients
Last imported at : May 25, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
Moderate/severe/critical disease at enrollment |
|
Severity scale
Last imported at : May 25, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
5: Moderate/severe/critical disease at enrollment |
|
Total sample size
Last imported at : May 13, 2022, 7 a.m. Source : ClinicalTrials.gov |
833 |
|
primary outcome
Last imported at : May 25, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
Ordinal scale |
|
Notes
Last imported at : May 25, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
None |
|
Phase
Last imported at : Nov. 16, 2021, 6:30 p.m. Source : ClinicalTrials.gov |
Not reported |
|
Arms
Last imported at : May 25, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
[{"arm_notes": "", "treatment_id": 92, "treatment_name": "Antimicrobial stewardship prospective audit and feedback", "treatment_type": "Care protocol", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}] |